Lilly Extends Collaboration With Cancer Institute

Posted: Updated:
INDIANAPOLIS -

Eli Lilly and Company (NYSE: LLY) has announced a three-year extension of its collaboration with Dana-Farber Cancer Institute. Scientists from each organization have been working together on various cancer care elements since 2015.

"This collaboration provides an opportunity for scientists and clinicians at a premier cancer center to bring creative new ideas about the underlying science and how this might drive future clinical opportunities for multiple Lilly therapeutic candidates," said Levi Garraway, M.D., Ph.D., senior vice president, global development and medical affairs, Lilly Oncology. "The extension will provide continued funding for initial testing of several such ideas in the lab and in the clinic, which could eventually inform new treatment avenues for cancer patients."

Lilly scientists have been allowed access to Dana-Farber scientists to develop pre-clinical and clinical compounds in Lilly's pipeline, and Dana-Farber scientists were granted permission to conduct studies on some Lilly compounds. All compounds studied in the collaboration will still be owned by Lilly. Financial terms of the agreement have not been disclosed. To learn more about Lilly's cancer treatment efforts, click here

  • Perspectives

    • How Managers Can Keep Millennials Happy

      There are more than 56 million Millennials either actively participating in the workforce, or searching for a job. With a number like this, it’s no surprise that Millennials have taken the workplace by storm. But what is surprising is how different this generation is from their predecessors. They rely heavily on technology and prefer to communicate via text or email rather than a traditional phone call. Managing millennial employees can be a challenge — how can executives...

    More

Subscribe

Name:
Company Name:
Email:
Confirm Email:
HTML
INside Edge
Morning Briefing
BigWigs & New Gigs
Life Sciences Indiana
Indiana Connections
INPower
Subscribe
Unsubscribe

Events



  • Most Popular Stories

    • $25M Behavioral Hospital Coming to Central Indiana

      Danville-based Hendricks Regional Health is partnering with US HealthVest to develop a stand-alone behavioral center on the Hendricks campus in Plainfield. Known as the Indianapolis Behavioral Hospital, the facility will provide specialized inpatient and outpatient mental health care to patients of all ages.

    • 'Heartbreaking' End For Nashville House

      The 91-year-old Nashville House restaurant is closing. The Brown County family dining staple will serve its last meal at the end of the month. In a post on Facebook, Gina Sarah Rogers, daughter of late-owners Andy and Fran Rogers, said it is "the end of an era and very heartbreaking." The restaurant is known for its country-style fried chicken and ham meals. Business on the property dates back to the late-1860s when an inn opened. It was acquired in...

    • High Alpha Spawns Tenth Tech Startup

      The first company has launched from Indianapolis-based High Alpha since the venture studio received a $100 million infusion in July, and the tenth overall. Anvl develops software designed to reduce and prevent maintenance service industry injuries. The company is led by Hoosier tech scene veteran Robin Fleming, who previously served as vice president of technology for Angie's List before its acquisition by New York-based IAC (Nasdaq: IAC). Anvl was born out of a first-of-its-kind...

    • (Image courtesy of Endocyte)

      $2.1B Endocyte Deal a Record-Breaker

      A veteran of Indiana's life sciences industry says the proposed blockbuster sale of West Lafayette-based Endocyte Inc. (Nasdaq: ECYT) is good for the ecosystem in the state. Switzerland-based Novartis AG has signed an agreement to acquire Endocyte for $2.1 billion, which BioCrossroads Project Director Brian Stemme says is "by far" the largest-ever acquisition of an Indiana life sciences company. The deal still faces regulatory and shareholder hurdles.

    • The MedTech Park would include a medical office building to house Central Indiana Orthopedics' Fishers operations.

      Construction on MedTech Park to Begin

      Officials in Fishers will Friday break ground on the first portion of the $13 million MedTech Park project. Muncie-based Central Indiana Orthopedics, which first proposed the development more than two years ago, says construction will begin on a 50,000-square-foot medical office building.